Single User License
INR 202133
Site License
INR 404265
Corporate User License
INR 606398

Service Tax Additional

select a format
Price

Single User License
USD 2995
Site License
USD 5990
Corporate User License
USD 8985

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects

The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects


  Request for Sample Report

Executive Summary

The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects

GBI Research's latest report, "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current market drivers and restraints, mergers and acquisitions (M&A) activity and recent regulatory developments in key national markets. Furthermore, this report analyses leading therapeutic segments in the OTC drugs market, key brands, manufacturers and the potential for new product categories to be created as more prescription-only drugs from diverse therapy areas continue to be considered for OTC approval. Detailed case studies of recent Rx-to-OTC switches provide the rationale for these switches including description of their economic and financial impact.

The OTC drugs market remains highly competitive and fragmented albeit leading companies continue to consolidate their market position through high-profile and strategic acquisitions. GBI Research expects M&A to remain very active in the coming years fueled by strategic long-term commercial priorities, as companies look to increase revenues through expanded OTC portfolios. A positive regulatory outlook in key markets, due to new initiatives and frameworks looking to facilitate OTC approvals, will also prompt companies to seek access to new markets. The global OTC drugs market will continue to be largely driven by demographics, economic trends and changes in cultural attitudes towards self-medication. An increasing interest in self-medication in both developed and developing countries has been identified as a major contributor to market growth in recent years.

GBI Research conducted extensive primary and secondary research efforts in order to provide a comprehensive view of the regulatory, commercial and competitive landscape in the OTC drugs market. Our new report will let you assess the most promising commercial areas in the market and help you identify key opportunities and challenges.

Scope

How do consumers, payers and manufacturers benefit from Rx-to-OTC switches?

What are the key factors promoting the usage of OTC drugs?

Current trends in the OTC drugs market

What attitudes do consumers have towards OTC drugs?

How are new distribution channels, technologies and education reshaping the OTC drugs market?

What will be the impact of new regulatory initiatives and frameworks on future Rx-to-OTC switches in key markets?

What have been the preferred types of M&A deals in the OTC drugs market in recent years?

Which OTC drug manufacturers have been the most active in terms of mergers and acquisitions in recent years?

What are the current regulations and frameworks established in key developed and developing markets for OTC approval and Rx-to-OTC switches?

Which OTC drug product categories and drug classes have experienced the most switches in recent years?

Which new products categories are expected to enter the OTC drugs market in the coming years?

What has been the economic and financial impact of recent Rx-to-OTC switches?

Who are the leading OTC drug manufacturers and what are their OTC segments of interest?

Market analysis of the leading OTC product categories including cough, cold, and allergy, analgesics, gastrointestinal and dermatological drugs.

Reasons To Buy

This report will allow you to

Gain insights into the OTC drugs market and future prospects for Rx-to-OTC switches: This report comprehensively describes and assesses the commercial, regulatory and competitive landscape in this highly dynamic and lucrative industry.

Understand differing regulatory frameworks for OTC drugs and Rx-to-OTC switches in key markets: This report provides insights about established regulatory processes, approval frameworks and recent developments in the US, Europe, Japan, India and China for OTC drugs.

Assess M&A activity in the OTC drugs market: This report provides detailed analysis on M&A deals in recent years including trends on preferred types of deals, factors contributing to the surge in transactions and identifies the most active companies in the OTC drugs market.

Assess the market for the leading OTC product categories: Our new study provides market analyses of the key product categories including revenues in key national markets, key brands, key manufacturers, market drivers, restraints, recent switches and potential candidates for future Rx-to-OTC switch.

Introduction

Key Global Trends in the OTC Drugs Market

US

Europe

APAC (India, China, Japan)

M&A Activity in the OTC Drugs Market: Leading Companies Consolidating their Market Position

Deal Analysis by Value, Type and Subtype

Drivers of the OTC Drugs Market

Barriers of the OTC Drugs Market

Current Regulations Surrounding OTC Drugs and Rx-to-OTC Switches

US

Europe

APAC

Recent Regulatory Trends and Developments in the OTC Drugs Market

US

Europe

APAC

Impact of Initiatives and Regulations (NSURE, Affordable Care Act) on Future Rx-to-OTC Switches

Rx-to-OTC Switch Case Studies: Key Benefits, Economic and Financial Impact

Nexium 24HR

Nasacort Allergy 24HR

Rhinocort Nasal Spray

Oxytrol For Women

Nicotine Replacement Therapies

Future Trends in the OTC Drugs Market and Rx-to-OTC Switches

Potential Drug Candidates for Future Rx-to-OTC Switch

Leading OTC Drug Manufacturers and Segments of Interest

Importance of Rx-to-OTC Strategies

Life Sciences Companies

Pharmacies

Others

Leading Product Categories in the OTC Drugs Market

Cough, Cold and Allergy OTC Drugs

Leading Brands and Key Manufacturers

Market Analysis

Analgesic OTC Drugs

Leading Brands and Key Manufacturers

Market Analysis

Dermatology OTC Drugs

Leading Brands and Key Manufacturers

Market Analysis

Gastrointestinal OTC Drugs

Leading Brands and Key Manufacturers

Market Analysis

Appendix

Bibliography

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

OTC, over-the-counter pharmaceuticals market, Rx-to-OTC Switch, attitude towards self-medication


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com